- Home
- FLYE vs MTNB Comparison
FLYE vs MTNB Comparison
Compare FLYE & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$1.78
N/A
Current Price
$1.23
Company Overview
Basic Information| Metric | FLYE | MTNB |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3M | 2.6M |
| IPO Year | 2024 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FLYE | MTNB |
|---|---|---|
| Price | $1.78 | $1.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 5.0M | 68.6K |
| Earning Date | 12-17-2026 | 08-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.82 | 59.84 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,063,357.00 | $119,750.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.22 | $0.15 |
| 52 Week High | $109.00 | $3.16 |
Technical Indicators
Market Signals| Indicator | FLYE | MTNB |
|---|---|---|
| Relative Strength Index (RSI) | 46.18 | 42.03 |
| Support Level | $1.51 | $0.56 |
| Resistance Level | $2.04 | $3.16 |
| Average True Range (ATR) | 0.48 | 0.25 |
| MACD | -0.09 | -0.13 |
| Stochastic Oscillator | 3.94 | 28.02 |
Price Performance
Historical Comparison FLYE
MTNB
About FLYE Fly-E Group Inc.
Fly-E Group Inc is principally engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters, and related accessories under the Fly E-Bike brand. It offers 27 E-motorcycle products, 37 E-bike products and 38 E-scooter products.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.